CN Patent

CN109069410B — 用于治疗血液恶性肿瘤和实体瘤的idh1抑制剂

Assigned to Xinji · Expires 2022-05-31 · 4y expired

What this patent protects

本文提供用于治疗携带IDH1突变或IDH2突变的患者的癌症的方法和组合物。

USPTO Abstract

本文提供用于治疗携带IDH1突变或IDH2突变的患者的癌症的方法和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN109069410B
Jurisdiction
CN
Classification
—
Expires
2022-05-31
Drug substance claim
No
Drug product claim
No
Assignee
Xinji
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.